![Frontiers | Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients Frontiers | Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients](https://www.frontiersin.org/files/Articles/499439/fimmu-11-00854-HTML/image_m/fimmu-11-00854-g001.jpg)
Frontiers | Analysis of the Targets and Glycosylation of Monoclonal IgAs From MGUS and Myeloma Patients
![Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia - Lucia Paolini, Giuseppe Di Noto, Francesca Maffina, Giovanni Martellosio, Annalisa Radeghieri, Caimi Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia - Lucia Paolini, Giuseppe Di Noto, Francesca Maffina, Giovanni Martellosio, Annalisa Radeghieri, Caimi](https://journals.sagepub.com/cms/10.1177/0004563214564225/asset/images/large/10.1177_0004563214564225-fig4.jpeg)
Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia - Lucia Paolini, Giuseppe Di Noto, Francesca Maffina, Giovanni Martellosio, Annalisa Radeghieri, Caimi
![Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia - Lucia Paolini, Giuseppe Di Noto, Francesca Maffina, Giovanni Martellosio, Annalisa Radeghieri, Caimi Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia - Lucia Paolini, Giuseppe Di Noto, Francesca Maffina, Giovanni Martellosio, Annalisa Radeghieri, Caimi](https://journals.sagepub.com/cms/10.1177/0004563214564225/asset/images/large/10.1177_0004563214564225-fig3.jpeg)
Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia - Lucia Paolini, Giuseppe Di Noto, Francesca Maffina, Giovanni Martellosio, Annalisa Radeghieri, Caimi
![Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbmt.2011.244/MediaObjects/41409_2012_Article_BFbmt2011244_Fig4_HTML.jpg)
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
![A) Serum immunofixation electrophoresis revealing IgG-κ gammopathy.... | Download Scientific Diagram A) Serum immunofixation electrophoresis revealing IgG-κ gammopathy.... | Download Scientific Diagram](https://www.researchgate.net/publication/305309280/figure/fig1/AS:616374271483924@1523966486890/A-Serum-immunofixation-electrophoresis-revealing-IgG-k-gammopathy-B-Bone-marrow.png)
A) Serum immunofixation electrophoresis revealing IgG-κ gammopathy.... | Download Scientific Diagram
![Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology](https://img.medscapestatic.com/thumbnail_library/920799.jpg)
Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology
![PDF) The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and monoclonal gammopathy of renal significance PDF) The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and monoclonal gammopathy of renal significance](https://www.researchgate.net/profile/Artur-Jurczyszyn/publication/327369928/figure/fig5/AS:902312914612224@1592139571217/Biological-events-related-to-progression-to-multiple-myeloma-Adapted-from-Korde-N_Q320.jpg)
PDF) The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and monoclonal gammopathy of renal significance
![Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma - Donk - 2016 - International Journal of Laboratory Hematology - Wiley Online Library Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma - Donk - 2016 - International Journal of Laboratory Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/97fd0625-c27c-437a-8d9d-16391322a53d/ijlh12504-fig-0002-m.jpg)
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma - Donk - 2016 - International Journal of Laboratory Hematology - Wiley Online Library
![PDF) Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: A matter of undetermined significance PDF) Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: A matter of undetermined significance](https://www.researchgate.net/profile/David-Kaplan-9/publication/51868367/figure/fig1/AS:394030534938629@1470955608216/Example-of-secondary-MGUS-demonstrated-by-SPEP-in-patient-no-1_Q320.jpg)
PDF) Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: A matter of undetermined significance
![When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2022/edbk.2022.42/edbk_349643/20230421/images/large/edbk_349643_table1.jpeg)
When a Monoclonal Gammopathy Is Not Multiple Myeloma | American Society of Clinical Oncology Educational Book
![Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0163-4/MediaObjects/41375_2018_163_Fig3_HTML.jpg)